Back

Pleomorphic ventricular tachycardia in dilated cardiomyopathy is a strong predictor of VT recurrence after ablation independent of cardiac function: Comparison with ischemic cardiomyopathy

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: New insights in ventricular arrhythmias II Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Yoshitaka Kimura

Leiden University Medical Center, Leiden (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Left ventricular non-compaction cardiomyopathy: additional predictors of life-threatening events for selecting patients for cardioverter-defibrillator implantation
Mrs N. Rineiska (Minsk, BY)
Abstract Slides Video
Presentation thumbnail
A novel ventricular map of electrograms duration as a method to identify areas of slow conduction during ablation of ventricular tachycardia
Doctor P. Rossi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Subsequent shock delivery and outcomes in out-of-hospital cardiac arrests with initial unshockable rhythm
Professor Y. Goto (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Accuracy of electroanatomical mapping guided cardiac radiotherapy for ventricular arrhytmias: pitfalls and solutions
Doctor S. Abdel-Kafi (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Prospective evaluation of a hybrid clinical and electrocardiographic algorithm to predict the origin of outflow tract PVCs. A prospective multicenter study.
Doctor J. Carreno Lineros (Huelva, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New insights in ventricular arrhythmias II

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources